SCHEMBL95330

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL10192135	0.81	PGR (0.51)	PGRKIF11CYP17A1HPGDLMNA
	SCHEMBL14466586	0.81	PGR (0.48)	PGRKIF11CYP17A1HPGDLMNA
	SCHEMBL10622850	0.81	KMT2A (0.47)	PGRKIF11HPGDLMNACA2
	SCHEMBL13797611	0.79	PGR (0.49)	PGRKIF11CYP17A1HPGDLMNA
	SCHEMBL6798952	0.79	PGR (0.46)	PGRKIF11CYP17A1HPGDLMNA
	SCHEMBL4129798	0.78	PGR (0.48)	PGRKIF11CYP17A1HPGDLMNA
	SCHEMBL7988528	0.76	HPGD (0.64)	PGRKIF11HPGDLMNAHTT
	SCHEMBL13034867	0.76	ALDH1A1 (0.50)	PGRKIF11HPGDLMNAHTT
	SCHEMBL12678580	0.75	PGR (0.46)	PGRKIF11CYP17A1HPGDLMNA
	SCHEMBL7435640	0.75	PTPN1 (0.63)	KIF11SMN1; SMN2CA2CA1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.